Peptides DB
Research-centric peptide and protocol reference hub
Study 14 of 15Kisspeptin (KP-10) literatureHuman vaccines & immunotherapeutics2026

Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025.

A 10% reduction in T cell epitope conservation may impact the efficacy of vaccines against the dominant influenza subclade K.

Read at Human vaccines & immunotherapeuticsAdd to compare

Where it sits

this study against the rest of the kisspeptin (kp-10) corpus
1
Preclinical · this one
12
Observational
0
Open-label
2
Randomised
0
Reviews

Summary and findings

This study assessed T cell epitope cross-conservation in the newly emergent influenza subclade K compared to other H3N2 strains and seasonal vaccines. A 10% reduction in cross-conserved T cell epitope content was observed. The findings suggest implications for vaccine efficacy against subclade K.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
10% reduction in cross-conserved T cell epitope content.2026

Abstract

The authors’ words, as Human vaccines & immunotherapeutics supplied them

Subclade K is a newly emergent influenza A/H3N2 strain that became the dominant strain circulating globally; more than 90% of influenza A virus (IAV) cases in 2025-26 were subclade K. While seasonal vaccines elicited measurable cross-reactive hemagglutination inhibition (HI) and neutralizing antibody responses against the new strain were deemed to be protective, T cells contribute substantially to protection against infection and severe disease. T cell epitopes that are conserved between vaccine strains and circulating strains may have a protective effect. We hypothesized that mutations in the HA antigen introduced by viral evolution resulted in the loss of some cross-conserved T cell epitopes and that this loss may have contributed to the emergence of subclade K. Using a new immunoinformatics tool, EpiCC, we assessed T cell epitope cross-conservation between subclade K, other circulating H3N2 strains, and the most recent seasonal vaccine strains. Evaluation of 706 H3N2 HA sequences demonstrated a 10% reduction in cross-conserved T cell epitope content between seasonal vaccines, circulating strains and subclade K. Decreased cross-conservation may signal the emergence of new flu strains. Proactive analysis of cross-conserved T cell epitopes may improve vaccine selection. Loss of T cell epitopes could also reduce the efficacy of new subclade K influenza vaccines in fall 2026.

Elsewhere in the Kisspeptin (KP-10) corpus

BFrom subtle symptoms to disclosure: Communication in violence detection in primary care.The European journal of general practice · 2026 · 25/326 patients disclosed experiences of violence.HumanCVirulence attenuation in ST11-K64 <i>Klebsiella pneumoniae</i> explains its divergent clinical manifestation from ST23-K1.Virulence · 2026 · 157 (18.5%) of 847 clinical Klebsiella pneumoniae isolates were identified as hv-CRKP.AnimalCHigh-Fat Diet Induces Epigenetic and Metabolic Changes in Kisspeptin Neurons in Association with Obesity and Male Secondary Hypogonadismbiorxiv-preprint · 2025 · Not reported in abstract.AnimalBInactivating PLEKHA6 Mutations Cause Idiopathic Hypogonadotropic Hypogonadism Through Impaired Kisspeptin Secretionbiorxiv-preprint · 2023 · n=1822 · Not reported in abstract.HumanANVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.Human vaccines & immunotherapeutics · 2026 · n=176 · 50% neutralization titers against strain XBB.1.16 boosted by 3.2-fold in monovalent mRNA, 4.1-fold in bivalent mRNA, and 1.6-fold in NVX-CoV2373 at day 28.HumanBSafety of COVID-19 mRNA-1273 booster doses in Asian populations: A literature review of post-marketing observational studies.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.review